CCL2 and CXCL12 Derived from Mesenchymal Stromal Cells Cooperatively Polarize IL-10+ Tissue Macrophages to Mitigate Gut Injury

Mesenchymal stromal cell (MSC)-based therapy for inflammatory diseases involves paracrine and efferocytotic activation of immunosuppressive interleukin-10(+) (IL-10(+)) macrophages. The paracrine pathway for MSC-mediated IL-10(+) macrophage functionality and response to tissue injury is not fully un...

Descripción completa

Detalles Bibliográficos
Autores principales: Giri, Jayeeta, Das, Rahul, Nylen, Emily, Chinnadurai, Raghavan, Galipeau, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043065/
https://www.ncbi.nlm.nih.gov/pubmed/32049021
http://dx.doi.org/10.1016/j.celrep.2020.01.047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043065/
https://www.ncbi.nlm.nih.gov/pubmed/32049021
http://dx.doi.org/10.1016/j.celrep.2020.01.047

Ejemplares similares